Biotech and Pharmaceuticals Medicine


  • Stations Nix Nicorette's 'Sucky' Ad Copy Thursday, 7 Jan 2010 | 1:32 PM ET

    GlaxoSmithKline can fuggedaboutit. If New York radio listeners have a problem with the company's new ad campaign for Nicorette, then how will it possibly play in Peoria?

  • A Drug’s Second Act: Battling Jet Lag Thursday, 7 Jan 2010 | 11:24 AM ET
    Airplane Takeoff

    For Cephalon, a company in Frazer, Pa., whose business tactics have attracted federal attention, the approval for jet lag is part of a plan to extend patent protection for its core franchise in stay-awake drugs.

  • Diet Drug Maker Glaxo to Pay for a Film on Eating Thursday, 7 Jan 2010 | 10:14 AM ET

    GlaxoSmithKline is getting into the movie business, pursuing an unusual and most likely controversial strategy to increase interest in a weight-loss drug. The New York Times reports.

  • Still Fixing Pfizer Wednesday, 6 Jan 2010 | 2:02 PM ET
    Jeff Kindler, Pfizer Chairman and CEO

    No one in their right mind, especially in this economy, likes to see someone lose their job. (Well, unless you really can't stand the person.) But, on the other hand, when you hear the top exec of the world's biggest drug company talk candidly about how much fat there was (is?) at Pfizer, can you really blame him for swinging the ax?

  • Taking A High-Tech Approach To Good Health Tuesday, 5 Jan 2010 | 3:41 PM ET

    With the home medical equipment market expected to expand at a steady clip over the next few years, consumer electronics companies are eager to expand their minimal presence.

  • Another Biotech CEO Bites The Dust Tuesday, 5 Jan 2010 | 3:18 PM ET
    James C. Mullen

    Talk about a blow to the ego. The shares may have since succumbed to the downdraft in the overall stock market, but when trading opened this morning Biogen Idec shot up around two percent. Investors were reacting to the news that the company's longtime CEO, Jim Mullen, is calling it quits.

  • Farrell: What Did Ben Say? Tuesday, 5 Jan 2010 | 11:18 AM ET
    Federal Reserve Bank Chairman Ben Bernanke

    Time magazine's Man of the Year Ben Bernanke gave a speech this past weekend, and at first I thought he was defending the excessively loose monetary policy that led to the recent crisis.

  • Novartis Has Eyes For Alcon Monday, 4 Jan 2010 | 1:17 PM ET

    Well, that didn't take long. It's only the first business day of the new year and big pharma's already gettin' down to business. Novartis is buying the rest of its Swiss neighbor Alcon for a cool $38.5 billion.

  • Biotech On The Big Screen Thursday, 31 Dec 2009 | 10:50 AM ET
    Brendan Fraser and Harrison Ford in Extraordinary Measures

    Usually I wouldn’t devote a blog to a biotech with a market value of approximately $86 million.  But when your personal story goes Hollywood—as in mega-watt stars like Harrison Ford and Brendan Fraser playing the lead roles in the movie—then you get a blog. 

  • Health Cuts With Little Effect on Care Wednesday, 30 Dec 2009 | 10:47 AM ET
    Stethescope and money

    At the heart of the health care debate is the question of whether it’s possible to cut medical costs without harming patients. What has happened in Richmond, Virginia helps to answer that question.

  • Glaxo Sucks Times Ten Monday, 28 Dec 2009 | 10:53 AM ET

    When I blogged last week about GlaxoSmithKline using the word “suck” in its new Nicorette ad campaign I thought it would be a one and done thing.

  • On Gaining More Impotence & Weightloss Drugs Wednesday, 23 Dec 2009 | 12:08 PM ET

    I can’t wait until this drug rises to the level where it gets on Joe Kernen’s radar screen because, boy, is he gonna have a good time (not just with the drug perhaps, but mostly with talking on TV about it.) A little TMI, I know, but that’s Joe.

  • Next Health Reform Showdown: House Versus Senate Wednesday, 23 Dec 2009 | 10:40 AM ET
    Healthcare coverage and the hastle of forms

    Our health care system  suffers from soaring costs and uneven quality. For health reform to be a success, it needs to make major progress on those problems. Here's a guide to the coming negotiations between the House and Senate aimed at closing the gaps between their two versions of reform legislation.

  • Does Glaxo's Ad Campaign Suck Or What? Tuesday, 22 Dec 2009 | 11:27 AM ET

    It's New Year's resolution time, so it's no surprise to see a sudden increase in commercials and ads for stop-smoking products. Pfizer's been heavily pushing its challenged Chantix and the other day I saw a commercial for GlaxoSmithKline's Nicorette that nearly made my jaw drop.

  • Tony Fratto: The Coming Health Spending Blizzard Tuesday, 22 Dec 2009 | 11:03 AM ET
    Healthcare coverage and the hastle of forms

    As senators made their way to Capitol Hill this weekend, a confluence of meteorological conditions conspired to dump nearly two feet of snow on Washington, DC.  Unlike the decisions being made under the Capitol dome, we’ll soon dig ourselves out from the mountains of snow.

  • Pharma’s Holiday Shopping Spree Monday, 21 Dec 2009 | 1:13 PM ET

    This morning biopharma P & A reached critical mass. In a rare, holiday-week confluence, four major pharmaceutical companies announced partnership deals and one announced a nearly $2-billion acquisition. All of the partnerships are on drugs that are still in the testing stage. If they were to all come to fruition, which in the risky business of drug development is highly unlikely, the new partnerships could collectively be worth billions of dollars over time.

  • Deep in Health Bill, Very Specific Beneficiaries Monday, 21 Dec 2009 | 10:57 AM ET
    Stethescope and money

    The New York Times reports on some of the hidden compromises in the final version of the Senate's health care reform bill.

  • Busch: Xmas and Health Care Monday, 21 Dec 2009 | 10:49 AM ET

    If you have had the misfortune to follow this debate as it grinds through the Senate, several thoughts come to mind.

  • Farrell: The Health Care Bill & Stocks We Like Monday, 21 Dec 2009 | 10:00 AM ET
    Healthcare coverage and the hastle of forms

    There is nothing in this bill that changes our views at Soleil regarding the health care stocks we have been recommending.

  • The Poop On Genzyme Thursday, 17 Dec 2009 | 10:32 AM ET

    I went to the beleaguered Genzyme manufacturing plant in Allston, MA yesterday to get briefed on what exactly happened/is happening there for background ahead of my interview today with the CEO.